Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1990-8-16
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0887-6924
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
312
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2366585-Aged,
pubmed-meshheading:2366585-Cytarabine,
pubmed-meshheading:2366585-Female,
pubmed-meshheading:2366585-Gene Rearrangement,
pubmed-meshheading:2366585-Humans,
pubmed-meshheading:2366585-Karyotyping,
pubmed-meshheading:2366585-Leukemia, Myeloid, Acute,
pubmed-meshheading:2366585-Male,
pubmed-meshheading:2366585-Middle Aged
|
pubmed:year |
1990
|
pubmed:articleTitle |
Cytogenetics are a predictive factor of response to low dose Ara-C in acute myelogenous leukemia (AML) in the elderly.
|
pubmed:publicationType |
Letter
|